US02155H2004
US02155H2004
Altimmune, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 41.000 | 20.000 | 105.0% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 94.530.000 | 103.192.000 | 8.4% | |
| Operating Income | -94.489.000 | -103.172.000 | 8.4% |
| Pretax Income | -88.774.000 | -95.059.000 | 6.6% |
| Net Income Common Stockholders | -88.093.000 | -95.059.000 | 7.3% |
| -- | -- | -- | |
| -- | -- | -- |